| Period Ending | Mar 30, 2012 | Dec 30, 2011 | Sep 29, 2011 | Jun 29, 2011 |
|---|
|
Total Revenue
|
146,613
|
177,690
|
170,135
|
172,883
| | Cost of Revenue | 26,905 | 20,448 | 27,707 | 42,833 | | |
Gross Profit
|
119,708
|
157,242
|
142,428
|
130,050
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 17,592 | 10,800 | 12,540 | 8,897 |
|
Non Recurring | 1,591 | 11,962 | 2,757 | 48,087 |
|
Others | 88,710 | 71,064 | 81,437 | 78,089 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
11,815
|
90,416
|
45,694
|
(5,023)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (58,931) | (20,115) | 86,761 | 37,068 |
|
Earnings Before Interest And Taxes | (47,116) | 43,301 | 132,455 | 32,045 |
|
Interest Expense | 73,854 | 76,528 | 77,355 | 97,043 |
|
Income Before Tax | (120,970) | (33,227) | 55,100 | (64,998) |
|
Income Tax Expense | 10,551 | (20,716) | 44,136 | (14,494) |
|
Minority Interest | (7,379) | (9,668) | (9,829) | (3,562) |
|
|
|
Net Income From Continuing Ops | (138,900) | (22,175) | 1,135 | (52,975) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(138,900)
|
(22,175)
|
1,135
|
(52,975)
| | Preferred Stock And Other Adjustments | (6,179) | (6,313) | (6,726) | (2,786) | | |
Net Income Applicable To Common Shares
|
(145,079)
|
(28,492)
|
(5,591)
|
(56,852)
|
|
0.80%